ANASTROZOLE ERIS anastrozole 1 mg film-coated tablet blister pack

País: Australia

Idioma: inglés

Fuente: Department of Health (Therapeutic Goods Administration)

Ingredientes activos:

anastrozole, Quantity: 1 mg

Disponible desde:

Strides Pharma Science Pty Ltd

Designación común internacional (DCI):

Anastrozole

formulario farmacéutico:

Tablet, film coated

Composición:

Excipient Ingredients: sodium starch glycollate; lactose monohydrate; hypromellose; magnesium stearate; povidone; titanium dioxide; macrogol 400

Vía de administración:

Oral

Unidades en paquete:

30 tablets

tipo de receta:

(S4) Prescription Only Medicine

indicaciones terapéuticas:

First line treatment of advanced breast cancer in postmenopausal women with oestrogen/progesterone receptor positive disease. Treatment of advanced breast cancer in postmenopausal women with disease progression following tamoxifen therapy. Patients with oestrogen receptor negative disease and patients who have not responded to previous tamoxifen therapy rarely respond to ANASTROZOLE ERIS.

Resumen del producto:

Visual Identification: White to off-white, round, biconvex film coated tablet engraved with the letters "A 1" on one side and plain on the other; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 3 Years; Container Temperature: Store below 30 degrees Celsius

Estado de Autorización:

Licence status A

Fecha de autorización:

2012-09-24